General discussion, page-6173

26% increase in SP for CPH on OTC is a great start for them - now compare that to IHL which has excellent management (no Blumenthals here), looking to list on the NASDAQ (where the big boys play) and with a lot more ammunition than this other crowd - we'll be a lot closer to getting FDA approval for any number of our drugs than CPH will, I can almost guarantee it.

IHL has also developed its own psychedelics arm and not gone out and bought one ( CPH has gone out and acquired minnow psychedelics outfit Halucenex - they really need to do something about that name)

Fingers crossed we soon get an update on the proposed listing!

DYOR and GLTAH.....